Entrada Therapeutics Reports Third Quarter 2022 Financial Results

Go back to Entrada Therapeutics Reports Third Quarter 2022 Financial Results
(NASDAQ: TRDA) Delayed: 7.27 --0 (-0%)
Previous Close $7.27    52 Week High
Open $7.27    52 Week Low
Day High $7.27    P/E N/A 
Day Low $7.27    EPS
Volume 12